Posterior Segment Eye Disease Treatment Market, Global Outlook and Forecast 2022-2028

July 2022 | 66 pages | ID: P5A6B6BC140EEN
Market Monitor Global

Abstracts

This report contains market size and forecasts of Posterior Segment Eye Disease Treatment in Global, including the following market information:

Global Posterior Segment Eye Disease Treatment Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Posterior Segment Eye Disease Treatment market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Medical Treatement Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Posterior Segment Eye Disease Treatment include Santen Pharmaceuticals, Abbvie Inc., Bausch Health Companies Inc., F Hoffmann-La Roche, Merck & Co. Inc., Novartis AG, Alcon Inc., Rainbow Medical Ltd and Regeneron Pharmaceuticals Inc., etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Posterior Segment Eye Disease Treatment companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Posterior Segment Eye Disease Treatment Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Posterior Segment Eye Disease Treatment Market Segment Percentages, by Type, 2021 (%)

• Medical Treatement
• Operation

Global Posterior Segment Eye Disease Treatment Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Posterior Segment Eye Disease Treatment Market Segment Percentages, by Application, 2021 (%)

• Hospitals
• Clinics
• Others

Global Posterior Segment Eye Disease Treatment Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Posterior Segment Eye Disease Treatment Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Posterior Segment Eye Disease Treatment revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Posterior Segment Eye Disease Treatment revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Santen Pharmaceuticals
• Abbvie Inc.
• Bausch Health Companies Inc.
• F Hoffmann-La Roche
• Merck & Co. Inc.
• Novartis AG
• Alcon Inc.
• Rainbow Medical Ltd
• Regeneron Pharmaceuticals Inc.
• Second Sight Medical Products Inc.
• Aerie Pharmaceuticals

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Posterior Segment Eye Disease Treatment Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Posterior Segment Eye Disease Treatment Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL POSTERIOR SEGMENT EYE DISEASE TREATMENT OVERALL MARKET SIZE

2.1 Global Posterior Segment Eye Disease Treatment Market Size: 2021 VS 2028
2.2 Global Posterior Segment Eye Disease Treatment Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Posterior Segment Eye Disease Treatment Players in Global Market
3.2 Top Global Posterior Segment Eye Disease Treatment Companies Ranked by Revenue
3.3 Global Posterior Segment Eye Disease Treatment Revenue by Companies
3.4 Top 3 and Top 5 Posterior Segment Eye Disease Treatment Companies in Global Market, by Revenue in 2021
3.5 Global Companies Posterior Segment Eye Disease Treatment Product Type
3.6 Tier 1, Tier 2 and Tier 3 Posterior Segment Eye Disease Treatment Players in Global Market
  3.6.1 List of Global Tier 1 Posterior Segment Eye Disease Treatment Companies
  3.6.2 List of Global Tier 2 and Tier 3 Posterior Segment Eye Disease Treatment Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Posterior Segment Eye Disease Treatment Market Size Markets, 2021 & 2028
  4.1.2 Medical Treatement
  4.1.3 Operation
4.2 By Type - Global Posterior Segment Eye Disease Treatment Revenue & Forecasts
  4.2.1 By Type - Global Posterior Segment Eye Disease Treatment Revenue, 2017-2022
  4.2.2 By Type - Global Posterior Segment Eye Disease Treatment Revenue, 2023-2028
  4.2.3 By Type - Global Posterior Segment Eye Disease Treatment Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Posterior Segment Eye Disease Treatment Market Size, 2021 & 2028
  5.1.2 Hospitals
  5.1.3 Clinics
  5.1.4 Others
5.2 By Application - Global Posterior Segment Eye Disease Treatment Revenue & Forecasts
  5.2.1 By Application - Global Posterior Segment Eye Disease Treatment Revenue, 2017-2022
  5.2.2 By Application - Global Posterior Segment Eye Disease Treatment Revenue, 2023-2028
  5.2.3 By Application - Global Posterior Segment Eye Disease Treatment Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Posterior Segment Eye Disease Treatment Market Size, 2021 & 2028
6.2 By Region - Global Posterior Segment Eye Disease Treatment Revenue & Forecasts
  6.2.1 By Region - Global Posterior Segment Eye Disease Treatment Revenue, 2017-2022
  6.2.2 By Region - Global Posterior Segment Eye Disease Treatment Revenue, 2023-2028
  6.2.3 By Region - Global Posterior Segment Eye Disease Treatment Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Posterior Segment Eye Disease Treatment Revenue, 2017-2028
  6.3.2 US Posterior Segment Eye Disease Treatment Market Size, 2017-2028
  6.3.3 Canada Posterior Segment Eye Disease Treatment Market Size, 2017-2028
  6.3.4 Mexico Posterior Segment Eye Disease Treatment Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Posterior Segment Eye Disease Treatment Revenue, 2017-2028
  6.4.2 Germany Posterior Segment Eye Disease Treatment Market Size, 2017-2028
  6.4.3 France Posterior Segment Eye Disease Treatment Market Size, 2017-2028
  6.4.4 U.K. Posterior Segment Eye Disease Treatment Market Size, 2017-2028
  6.4.5 Italy Posterior Segment Eye Disease Treatment Market Size, 2017-2028
  6.4.6 Russia Posterior Segment Eye Disease Treatment Market Size, 2017-2028
  6.4.7 Nordic Countries Posterior Segment Eye Disease Treatment Market Size, 2017-2028
  6.4.8 Benelux Posterior Segment Eye Disease Treatment Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Posterior Segment Eye Disease Treatment Revenue, 2017-2028
  6.5.2 China Posterior Segment Eye Disease Treatment Market Size, 2017-2028
  6.5.3 Japan Posterior Segment Eye Disease Treatment Market Size, 2017-2028
  6.5.4 South Korea Posterior Segment Eye Disease Treatment Market Size, 2017-2028
  6.5.5 Southeast Asia Posterior Segment Eye Disease Treatment Market Size, 2017-2028
  6.5.6 India Posterior Segment Eye Disease Treatment Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Posterior Segment Eye Disease Treatment Revenue, 2017-2028
  6.6.2 Brazil Posterior Segment Eye Disease Treatment Market Size, 2017-2028
  6.6.3 Argentina Posterior Segment Eye Disease Treatment Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Posterior Segment Eye Disease Treatment Revenue, 2017-2028
  6.7.2 Turkey Posterior Segment Eye Disease Treatment Market Size, 2017-2028
  6.7.3 Israel Posterior Segment Eye Disease Treatment Market Size, 2017-2028
  6.7.4 Saudi Arabia Posterior Segment Eye Disease Treatment Market Size, 2017-2028
  6.7.5 UAE Posterior Segment Eye Disease Treatment Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Santen Pharmaceuticals
  7.1.1 Santen Pharmaceuticals Corporate Summary
  7.1.2 Santen Pharmaceuticals Business Overview
  7.1.3 Santen Pharmaceuticals Posterior Segment Eye Disease Treatment Major Product Offerings
  7.1.4 Santen Pharmaceuticals Posterior Segment Eye Disease Treatment Revenue in Global Market (2017-2022)
  7.1.5 Santen Pharmaceuticals Key News
7.2 Abbvie Inc.
  7.2.1 Abbvie Inc. Corporate Summary
  7.2.2 Abbvie Inc. Business Overview
  7.2.3 Abbvie Inc. Posterior Segment Eye Disease Treatment Major Product Offerings
  7.2.4 Abbvie Inc. Posterior Segment Eye Disease Treatment Revenue in Global Market (2017-2022)
  7.2.5 Abbvie Inc. Key News
7.3 Bausch Health Companies Inc.
  7.3.1 Bausch Health Companies Inc. Corporate Summary
  7.3.2 Bausch Health Companies Inc. Business Overview
  7.3.3 Bausch Health Companies Inc. Posterior Segment Eye Disease Treatment Major Product Offerings
  7.3.4 Bausch Health Companies Inc. Posterior Segment Eye Disease Treatment Revenue in Global Market (2017-2022)
  7.3.5 Bausch Health Companies Inc. Key News
7.4 F Hoffmann-La Roche
  7.4.1 F Hoffmann-La Roche Corporate Summary
  7.4.2 F Hoffmann-La Roche Business Overview
  7.4.3 F Hoffmann-La Roche Posterior Segment Eye Disease Treatment Major Product Offerings
  7.4.4 F Hoffmann-La Roche Posterior Segment Eye Disease Treatment Revenue in Global Market (2017-2022)
  7.4.5 F Hoffmann-La Roche Key News
7.5 Merck & Co. Inc.
  7.5.1 Merck & Co. Inc. Corporate Summary
  7.5.2 Merck & Co. Inc. Business Overview
  7.5.3 Merck & Co. Inc. Posterior Segment Eye Disease Treatment Major Product Offerings
  7.5.4 Merck & Co. Inc. Posterior Segment Eye Disease Treatment Revenue in Global Market (2017-2022)
  7.5.5 Merck & Co. Inc. Key News
7.6 Novartis AG
  7.6.1 Novartis AG Corporate Summary
  7.6.2 Novartis AG Business Overview
  7.6.3 Novartis AG Posterior Segment Eye Disease Treatment Major Product Offerings
  7.6.4 Novartis AG Posterior Segment Eye Disease Treatment Revenue in Global Market (2017-2022)
  7.6.5 Novartis AG Key News
7.7 Alcon Inc.
  7.7.1 Alcon Inc. Corporate Summary
  7.7.2 Alcon Inc. Business Overview
  7.7.3 Alcon Inc. Posterior Segment Eye Disease Treatment Major Product Offerings
  7.7.4 Alcon Inc. Posterior Segment Eye Disease Treatment Revenue in Global Market (2017-2022)
  7.7.5 Alcon Inc. Key News
7.8 Rainbow Medical Ltd
  7.8.1 Rainbow Medical Ltd Corporate Summary
  7.8.2 Rainbow Medical Ltd Business Overview
  7.8.3 Rainbow Medical Ltd Posterior Segment Eye Disease Treatment Major Product Offerings
  7.8.4 Rainbow Medical Ltd Posterior Segment Eye Disease Treatment Revenue in Global Market (2017-2022)
  7.8.5 Rainbow Medical Ltd Key News
7.9 Regeneron Pharmaceuticals Inc.
  7.9.1 Regeneron Pharmaceuticals Inc. Corporate Summary
  7.9.2 Regeneron Pharmaceuticals Inc. Business Overview
  7.9.3 Regeneron Pharmaceuticals Inc. Posterior Segment Eye Disease Treatment Major Product Offerings
  7.9.4 Regeneron Pharmaceuticals Inc. Posterior Segment Eye Disease Treatment Revenue in Global Market (2017-2022)
  7.9.5 Regeneron Pharmaceuticals Inc. Key News
7.10 Second Sight Medical Products Inc.
  7.10.1 Second Sight Medical Products Inc. Corporate Summary
  7.10.2 Second Sight Medical Products Inc. Business Overview
  7.10.3 Second Sight Medical Products Inc. Posterior Segment Eye Disease Treatment Major Product Offerings
  7.10.4 Second Sight Medical Products Inc. Posterior Segment Eye Disease Treatment Revenue in Global Market (2017-2022)
  7.10.5 Second Sight Medical Products Inc. Key News
7.11 Aerie Pharmaceuticals
  7.11.1 Aerie Pharmaceuticals Corporate Summary
  7.11.2 Aerie Pharmaceuticals Business Overview
  7.11.3 Aerie Pharmaceuticals Posterior Segment Eye Disease Treatment Major Product Offerings
  7.11.4 Aerie Pharmaceuticals Posterior Segment Eye Disease Treatment Revenue in Global Market (2017-2022)
  7.11.5 Aerie Pharmaceuticals Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Posterior Segment Eye Disease Treatment Market Opportunities & Trends in Global Market
Table 2. Posterior Segment Eye Disease Treatment Market Drivers in Global Market
Table 3. Posterior Segment Eye Disease Treatment Market Restraints in Global Market
Table 4. Key Players of Posterior Segment Eye Disease Treatment in Global Market
Table 5. Top Posterior Segment Eye Disease Treatment Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Posterior Segment Eye Disease Treatment Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Posterior Segment Eye Disease Treatment Revenue Share by Companies, 2017-2022
Table 8. Global Companies Posterior Segment Eye Disease Treatment Product Type
Table 9. List of Global Tier 1 Posterior Segment Eye Disease Treatment Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Posterior Segment Eye Disease Treatment Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Posterior Segment Eye Disease Treatment Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Posterior Segment Eye Disease Treatment Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Posterior Segment Eye Disease Treatment Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Posterior Segment Eye Disease Treatment Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Posterior Segment Eye Disease Treatment Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Posterior Segment Eye Disease Treatment Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Posterior Segment Eye Disease Treatment Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Posterior Segment Eye Disease Treatment Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Posterior Segment Eye Disease Treatment Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Posterior Segment Eye Disease Treatment Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Posterior Segment Eye Disease Treatment Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Posterior Segment Eye Disease Treatment Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Posterior Segment Eye Disease Treatment Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Posterior Segment Eye Disease Treatment Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Posterior Segment Eye Disease Treatment Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Posterior Segment Eye Disease Treatment Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Posterior Segment Eye Disease Treatment Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Posterior Segment Eye Disease Treatment Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Posterior Segment Eye Disease Treatment Revenue, (US$, Mn), 2023-2028
Table 30. Santen Pharmaceuticals Corporate Summary
Table 31. Santen Pharmaceuticals Posterior Segment Eye Disease Treatment Product Offerings
Table 32. Santen Pharmaceuticals Posterior Segment Eye Disease Treatment Revenue (US$, Mn), (2017-2022)
Table 33. Abbvie Inc. Corporate Summary
Table 34. Abbvie Inc. Posterior Segment Eye Disease Treatment Product Offerings
Table 35. Abbvie Inc. Posterior Segment Eye Disease Treatment Revenue (US$, Mn), (2017-2022)
Table 36. Bausch Health Companies Inc. Corporate Summary
Table 37. Bausch Health Companies Inc. Posterior Segment Eye Disease Treatment Product Offerings
Table 38. Bausch Health Companies Inc. Posterior Segment Eye Disease Treatment Revenue (US$, Mn), (2017-2022)
Table 39. F Hoffmann-La Roche Corporate Summary
Table 40. F Hoffmann-La Roche Posterior Segment Eye Disease Treatment Product Offerings
Table 41. F Hoffmann-La Roche Posterior Segment Eye Disease Treatment Revenue (US$, Mn), (2017-2022)
Table 42. Merck & Co. Inc. Corporate Summary
Table 43. Merck & Co. Inc. Posterior Segment Eye Disease Treatment Product Offerings
Table 44. Merck & Co. Inc. Posterior Segment Eye Disease Treatment Revenue (US$, Mn), (2017-2022)
Table 45. Novartis AG Corporate Summary
Table 46. Novartis AG Posterior Segment Eye Disease Treatment Product Offerings
Table 47. Novartis AG Posterior Segment Eye Disease Treatment Revenue (US$, Mn), (2017-2022)
Table 48. Alcon Inc. Corporate Summary
Table 49. Alcon Inc. Posterior Segment Eye Disease Treatment Product Offerings
Table 50. Alcon Inc. Posterior Segment Eye Disease Treatment Revenue (US$, Mn), (2017-2022)
Table 51. Rainbow Medical Ltd Corporate Summary
Table 52. Rainbow Medical Ltd Posterior Segment Eye Disease Treatment Product Offerings
Table 53. Rainbow Medical Ltd Posterior Segment Eye Disease Treatment Revenue (US$, Mn), (2017-2022)
Table 54. Regeneron Pharmaceuticals Inc. Corporate Summary
Table 55. Regeneron Pharmaceuticals Inc. Posterior Segment Eye Disease Treatment Product Offerings
Table 56. Regeneron Pharmaceuticals Inc. Posterior Segment Eye Disease Treatment Revenue (US$, Mn), (2017-2022)
Table 57. Second Sight Medical Products Inc. Corporate Summary
Table 58. Second Sight Medical Products Inc. Posterior Segment Eye Disease Treatment Product Offerings
Table 59. Second Sight Medical Products Inc. Posterior Segment Eye Disease Treatment Revenue (US$, Mn), (2017-2022)
Table 60. Aerie Pharmaceuticals Corporate Summary
Table 61. Aerie Pharmaceuticals Posterior Segment Eye Disease Treatment Product Offerings
Table 62. Aerie Pharmaceuticals Posterior Segment Eye Disease Treatment Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Posterior Segment Eye Disease Treatment Segment by Type in 2021
Figure 2. Posterior Segment Eye Disease Treatment Segment by Application in 2021
Figure 3. Global Posterior Segment Eye Disease Treatment Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Posterior Segment Eye Disease Treatment Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Posterior Segment Eye Disease Treatment Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Posterior Segment Eye Disease Treatment Revenue in 2021
Figure 8. By Type - Global Posterior Segment Eye Disease Treatment Revenue Market Share, 2017-2028
Figure 9. By Application - Global Posterior Segment Eye Disease Treatment Revenue Market Share, 2017-2028
Figure 10. By Region - Global Posterior Segment Eye Disease Treatment Revenue Market Share, 2017-2028
Figure 11. By Country - North America Posterior Segment Eye Disease Treatment Revenue Market Share, 2017-2028
Figure 12. US Posterior Segment Eye Disease Treatment Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Posterior Segment Eye Disease Treatment Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Posterior Segment Eye Disease Treatment Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Posterior Segment Eye Disease Treatment Revenue Market Share, 2017-2028
Figure 16. Germany Posterior Segment Eye Disease Treatment Revenue, (US$, Mn), 2017-2028
Figure 17. France Posterior Segment Eye Disease Treatment Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Posterior Segment Eye Disease Treatment Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Posterior Segment Eye Disease Treatment Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Posterior Segment Eye Disease Treatment Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Posterior Segment Eye Disease Treatment Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Posterior Segment Eye Disease Treatment Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Posterior Segment Eye Disease Treatment Revenue Market Share, 2017-2028
Figure 24. China Posterior Segment Eye Disease Treatment Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Posterior Segment Eye Disease Treatment Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Posterior Segment Eye Disease Treatment Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Posterior Segment Eye Disease Treatment Revenue, (US$, Mn), 2017-2028
Figure 28. India Posterior Segment Eye Disease Treatment Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Posterior Segment Eye Disease Treatment Revenue Market Share, 2017-2028
Figure 30. Brazil Posterior Segment Eye Disease Treatment Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Posterior Segment Eye Disease Treatment Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Posterior Segment Eye Disease Treatment Revenue Market Share, 2017-2028
Figure 33. Turkey Posterior Segment Eye Disease Treatment Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Posterior Segment Eye Disease Treatment Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Posterior Segment Eye Disease Treatment Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Posterior Segment Eye Disease Treatment Revenue, (US$, Mn), 2017-2028
Figure 37. Santen Pharmaceuticals Posterior Segment Eye Disease Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Abbvie Inc. Posterior Segment Eye Disease Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Bausch Health Companies Inc. Posterior Segment Eye Disease Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. F Hoffmann-La Roche Posterior Segment Eye Disease Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Merck & Co. Inc. Posterior Segment Eye Disease Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Novartis AG Posterior Segment Eye Disease Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Alcon Inc. Posterior Segment Eye Disease Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Rainbow Medical Ltd Posterior Segment Eye Disease Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Regeneron Pharmaceuticals Inc. Posterior Segment Eye Disease Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. Second Sight Medical Products Inc. Posterior Segment Eye Disease Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 47. Aerie Pharmaceuticals Posterior Segment Eye Disease Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)